Cargando…
ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489581/ https://www.ncbi.nlm.nih.gov/pubmed/32984770 http://dx.doi.org/10.1097/HS9.0000000000000467 |
| _version_ | 1783581883157708800 |
|---|---|
| author | Virely, Clemence Gasparoli, Luca Mangolini, Maurizio Clesham, Katherine Inglott, Sarah Edwards, Darren Adams, Stuart Bartram, Jack Samarasinghe, Sujith Ancliff, Philip Vora, Ajay de Boer, Jasper Williams, Owen |
| author_facet | Virely, Clemence Gasparoli, Luca Mangolini, Maurizio Clesham, Katherine Inglott, Sarah Edwards, Darren Adams, Stuart Bartram, Jack Samarasinghe, Sujith Ancliff, Philip Vora, Ajay de Boer, Jasper Williams, Owen |
| author_sort | Virely, Clemence |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7489581 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74895812020-09-24 ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia Virely, Clemence Gasparoli, Luca Mangolini, Maurizio Clesham, Katherine Inglott, Sarah Edwards, Darren Adams, Stuart Bartram, Jack Samarasinghe, Sujith Ancliff, Philip Vora, Ajay de Boer, Jasper Williams, Owen Hemasphere Letter Lippincott Williams & Wilkins 2020-09-11 /pmc/articles/PMC7489581/ /pubmed/32984770 http://dx.doi.org/10.1097/HS9.0000000000000467 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
| spellingShingle | Letter Virely, Clemence Gasparoli, Luca Mangolini, Maurizio Clesham, Katherine Inglott, Sarah Edwards, Darren Adams, Stuart Bartram, Jack Samarasinghe, Sujith Ancliff, Philip Vora, Ajay de Boer, Jasper Williams, Owen ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia |
| title | ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia |
| title_full | ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia |
| title_fullStr | ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia |
| title_full_unstemmed | ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia |
| title_short | ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia |
| title_sort | arhgef4 regulates an essential oncogenic program in t(12;21)-associated acute lymphoblastic leukemia |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489581/ https://www.ncbi.nlm.nih.gov/pubmed/32984770 http://dx.doi.org/10.1097/HS9.0000000000000467 |
| work_keys_str_mv | AT virelyclemence arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia AT gasparoliluca arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia AT mangolinimaurizio arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia AT cleshamkatherine arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia AT inglottsarah arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia AT edwardsdarren arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia AT adamsstuart arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia AT bartramjack arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia AT samarasinghesujith arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia AT ancliffphilip arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia AT voraajay arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia AT deboerjasper arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia AT williamsowen arhgef4regulatesanessentialoncogenicprogramint1221associatedacutelymphoblasticleukemia |